Oyepeju Abioye-Akintola, MD, MSc, says unreadable consent forms are a fixable barrier to oncology trial enrollment.
Oyepeju Abioye-Akintola, MD, MSc
Advertisement
Articles by Oyepeju Abioye-Akintola, MD, MSc
Oyepeju Abioye-Akintola, MD, MSc explains how the Protocol & People initiative revealed unreadable consent forms as a fixable barrier to clinical and equitable trial enrollment.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Four Major Idiopathic Pulmonary Fibrosis Advances From 2026
2
Machine Learning Has High Accuracy, Little Prospective Validation in MPNs
3
The Next Decade of Cancer Care Is Coming Home: Who Will Be in the Driver’s Seat?
4
BPC-157 'Wolverine Peptide' Use Rose 33-Fold Despite Scant Evidence
5